In this episode, we sit down with Dr. John Rumpakis to discuss the economics of PROKERA®, a biologic corneal bandage composed of preserved amniotic membrane tissue.
Importantly, we’ll learn how to properly bill & code when using this product with your patients.
And if you missed our previous radio show about the clinical aspects of PROKERA®, you can catch it here.
Dr. Rumpakis will be available to take questions in this thread, so fire away!
Blepharitis remains a significant source of discomfort for patients, and over the years docs have tried a variety of therapeutic approaches to treating the problem.
In this ODwire.org Radio show, we talk with Walter O. Whitley, OD, Director of Optometric Services at Virginia Eye Consultants about:
Please share your experience with ODwire.org members in the thread below, and if you have any questions for Dr. Whitley, ask them here.
We’re taught in school that generic drugs are identical to their brand-name equivalents.
But is that true? Are generics actually identical, or do differences in their composition and production processes lead to different clinical outcomes?
In this important ODwire.org Radio show, experienced clinicians Drs. Mel Friedman and Agustin Gonzalez talk about their research into this issue, and what you as a clinician should know when you write for generics vs. branded pharmaceuticals.
If you engage in patient care (or regularly take pharmaceuticals yourself), this is one episode you won’t want to miss!
